Cardiovascular Proteomics. Tools to Develop Novel Biomarkers and Potential Applications

Journal of the American College of Cardiology

Volumn 48, Issue 9, 2006, Pages 1733-1741

  Arab, Sara ^a,b   Gramolini, Anthony O ^a,b   Ping, Peipei ^d   Kislinger, Thomas ^a   Stanley, Brian ^c,e   van Eyk, Jennifer ^c,e   Ouzounian, Maral ^a,c   MacLennan, David H ^a   Emili, Andrew ^a   Liu, Peter P ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

AMINO ACID SEQUENCE; CARDIOVASCULAR DISEASE; GENOME; HAPLOTYPE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MASS SPECTROMETRY; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PHENOTYPE; PLASMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SERUM; TANDEM MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 33750469002     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.063     Document Type: Review

References (37)

1. White M.Y., Cordwell S.J., McCarron H.C., et al. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics 5 (2005) 1395-1410
2. Yan L., Vatner D.E., Kim S.J., et al. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci U S A 102 (2005) 13807-13812
3. Mateos-Caceres P.J., Garcia-Mendez A., Lopez Farre A., et al. Proteomic analysis of plasma from patients during an acute coronary syndrome. J Am Coll Cardiol 44 (2004) 1578-1583
4. Labugger R., Organ L., Collier C., Atar D., and Van Eyk J.E. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 102 (2000) 1221-1226
5. Gramolini A.O., Kislinger T., Liu P.P., MacLennan D.H., and Emili A. Analyzing the cardiac muscle proteome by liquid chromatography-mass spectrometry (LC-MS) based expression proteomics. Methods in Molecular Biology 357 (2006) 15-32
6. Buscemi N., Murray C., Doherty-Kirby A., Lajoie G., Sussman M.A., and Van Eyk J.E. Myocardial subproteomic analysis of a constitutively active Rac1-expressing transgenic mouse with lethal myocardial hypertrophy. Am J Physiol Heart Circ Physiol 289 (2005) H2325-H2333
7. Sawicki G., and Jugdutt B.I. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics 4 (2004) 2195-2202
8. Berhane B.T., Zong C., Liem D.A., et al. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 5 (2005) 3520-3530
9. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 563 (2005) 23-60
10. Stanley B.A., Gundry R.L., Cotter R.J., and Van Eyk J.E. Heart disease, clinical proteomics and mass spectrometry. Dis Markers 20 (2004) 167-178
11. Ping P. Identification of novel signaling complexes by functional proteomics. Circ Res 93 (2003) 595-603
12. Klose J., and Spielmann H. Gel isoelectric focusing of mouse lactate dehydrogenase: heterogeneity of the isoenzymes A4 and X4. Biochem Genet 13 (1975) 707-720
13. O'Farrell P.Z., and Goodman H.M. Resolution of simian virus 40 proteins in whole cell extracts by two-dimensional electrophoresis: heterogeneity of the major capsid protein. Cell 9 (1976) 289-298
14. Andersen J.S., Lam Y.W., Leung A.K., et al. Nucleolar proteome dynamics. Nature 433 (2005) 77-83
15. Gorg A., Weiss W., and Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 4 (2004) 3665-3685
16. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 97 (2000) 9390-9395
17. Kislinger T., Rahman K., Radulovic D., Cox B., Rossant J., and Emili A. PRISM, a generic large scale proteomic investigation strategy for mammals. Mol Cell Proteomics 2 (2003) 96-106
18. Kislinger T., and Emili A. Going global: protein expression profiling using shotgun mass spectrometry. Curr Opin Mol Ther 5 (2003) 285-293
19. Washburn M.P., Wolters D., and Yates III J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19 (2001) 242-247
20. Koller A., Washburn M.P., Lange B.M., et al. Proteomic survey of metabolic pathways in rice. Proc Natl Acad Sci U S A 99 (2002) 11969-11974
21. Le Roch K.G., Johnson J.R., Florens L., et al. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res 14 (2004) 2308-2318
22. Schirmer E.C., Florens L., Guan T., Yates III J.R., and Gerace L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science 301 (2003) 1380-1382
23. Abdo M., Irving B., Hudson P., and Zola H. Development of a cluster of differentiation antibody-based protein microarray. J Immunol Methods 305 (2005) 3-9
24. Ramachandran N., Hainsworth E., Bhullar B., et al. Self-assembling protein microarrays. Science 305 (2004) 86-90
25. Kricka L.J., and Master S.R. Validation and quality control of protein microarray-based analytical methods. Methods Mol Med 114 (2005) 233-255
26. Chan S.M., Ermann J., Su L., Fathman C.G., and Utz P.J. Protein microarrays for multiplex analysis of signal transduction pathways. Nat Med 10 (2004) 1390-1396
27. Diamandis E.P. Point: proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?. Clin Chem 49 (2003) 1272-1275
28. Anderson N.G., Willis D.D., Holladay D.W., et al. Analytical techniques for cell fractions. XX. Cyclic affinity chromatography: principles and applications. Anal Biochem 68 (1975) 371-393
29. Ping P., Vondriska T.M., Creighton C.J., et al. A functional annotation of subproteomes in human plasma. Proteomics 5 (2005) 3506-3519
30. Fu Q., Garnham C.P., Elliott S.T., Bovenkamp D.E., and Van Eyk J.E. A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics 5 (2005) 2656-2664
31. Colantonio D.A., Dunkinson C., Bovenkamp D.E., and Van Eyk J.E. Effective removal of albumin from serum. Proteomics 5 (2005) 3831-3835
32. Petricoin E.F., Ardekani A.M., Hitt B.A., et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359 (2002) 572-577
33. Petricoin E.F., Zoon K.C., Kohn E.C., Barrett J.C., and Liotta L.A. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1 (2002) 683-695
34. Verhoeckx K.C., Bijlsma S., de Groene E.M., Witkamp R.F., van der Greef J., and Rodenburg R.J. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 4 (2004) 1014-1028
35. Jones P., Cote R.G., Martens L., et al. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res 34 (2006) D659-D663
36. Proteomics' new order. Editors. Nature 437 (2005) 169-170
37. Human Proteome Organisation. Available at: http://www.hupo.org. Accessed October 12, 2006.